Codeine Phosphate Tablets 15mg

Product name and form


Pharmaceutical Form

White uncoated tablets.

Qualitative and quantitative composition

Each tablet contains 15mg Codeine Phosphate PhEur.

List of Excipients

Also contains lactose
Magnesium stearate
Maize starch
Pregelatinised maize starch
Stearic acid

Pack sizes and marketing

The product containers are rigid injection moulded polypropylene or injection blow-moulded polyethylene tablet containers with polyfoam wad or polyethylene ullage filler and snap-on polyethylene lids; in case any supply difficulties should arise the alternative is amber glass bottles with screw caps and polyfoam wad or cotton wool. An alternative closure for polyethylene containers is a polypropylene, twist on, push down and twist off child-resistant, tamper-evident lid.

The product may also be supplied in blister packs in cartons:

  • Carton: Printed carton manufactured from white folding box board.
  • Blister pack: (i) 250µm white rigid PVC. (ii) Surface printed 20µm hard temper aluminium foil with 5-7g/M² PVC and PVdC compatible heat seal lacquer on the reverse side.

Pack sizes: 28s, 30s, 50s, 56s, 60s, 84s, 90s, 100s, 112s, 120s, 168s, 180s, 250s, 500s, 1000s

Product may also be supplied in bulk packs, for reassembly purposes only, in polybags contained in tins, skillets or polybuckets filled with suitable cushioning material.

Maximum size of bulk packs: 50,000.

Marketing Authorization Holder
Authorization Dates

Name or style and permanent address of registered place of business of the holder of the Marketing Authorisation:

Actavis UK Limited
(Trading style: Actavis)
Whiddon Valley
N Devon
EX32 8NS

(Product Licence of Right issued: Pre 1974) 2.11.81 / 30.06.02

Marketing authorization number:

PL 0142/6458 R